Medinotec (MDNC) Change in Receivables (2022 - 2026)
Medinotec's (MDNC) quarterly Change in Receivables came in at -$172688.0 in Q2 2026, up 89.14% on a YoY basis from -$91303.9 in Q2 2025, and down 147.0% quarter-over-quarter from $367430.0 in Q1 2026.
Powered by 
Analysis
Medinotec (MDNC) Change in Receivables (2022 - 2026) Analysis & Trends
Medinotec (MDNC) has reported Change in Receivables for 5 consecutive years, with -$172688.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Receivables rose 89.14% year-over-year to -$172688.0; the trailing twelve-month figure through May 2026 stood at $1.7 million (up 142.59% YoY), and the FY2026 full-year result was $259965.0, up 112.75% from the prior year.
- Change in Receivables slipped to -$172688.0 in Q2 2026 per MDNC's latest filing, from $367430.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $1.3 million in Q3 2025 and bottomed at -$1.7 million in Q1 2025.
- Historically, Change in Receivables has averaged -$138598.7 across 5 years, with a median of -$3962.5 in 2022.
- The widest YoY moves for Change in Receivables: up 950.04% in 2023, down 2744.59% in 2023.
- Over 5 years, Change in Receivables stood at $258392.0 in 2022, then sank by 84.49% to $40082.0 in 2023, then tumbled by 671.85% to -$229210.0 in 2024, then soared by 172.28% to $165678.0 in 2025, then sank by 204.23% to -$172688.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$172688.0, $367430.0, and $165678.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | -172,688.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -172,688.00 |
| Feb 28, 2026 | 367,430.00 |
| Nov 30, 2025 | 165,678.00 |
| Aug 31, 2025 | 1.32 Mn |
| May 31, 2025 | -1.59 Mn |
| Feb 28, 2025 | -1.69 Mn |
| Nov 30, 2024 | -229,210.00 |
| Aug 31, 2024 | -432,543.00 |
| May 31, 2024 | 308,431.00 |
| Feb 29, 2024 | -576,092.00 |
| Nov 30, 2023 | 40,082.00 |
| Aug 31, 2023 | 144,388.00 |
| May 31, 2023 | -239,626.00 |
| Feb 28, 2023 | -271,486.00 |
| Nov 30, 2022 | 258,392.00 |
| Aug 31, 2022 | -16,986.00 |
| May 31, 2022 | 9,061.00 |
| Feb 28, 2022 | 109,460.00 |